Clinical Trials Directory

Trials / Completed

CompletedNCT03281512

Saturated Fatty Acids Intake and Mortality, Diabetes, Hypertension and Overweight

Saturated Fatty Acids Intake and Mortality, Diabetes, Hypertension and Overweight in the China Health and Nutrition Survey (CHNS)

Status
Completed
Phase
Study type
Observational
Enrollment
14,383 (actual)
Sponsor
Zhejiang University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

The role of saturated fatty acids (SFAs) intake in the development of total death, cardiovascular diseases, diabetes, hypertension and overweight are in great controversy but evidence from large population in China is scant.The investigators aim to use the data from the China Health and Nutrition Survey to assess the long-term association of SFAs intake with total mortality, diabetes, hypertension and overweight.

Detailed description

The role of saturated fatty acids (SFAs) intake in the development of total death, diabetes, hypertension and overweight are in great controversy but evidence from large population in China is lacking.The investigators aim to utilize the data from the China Health and Nutrition Survey. The investigators will calculate the cumulative average intake of SFAs based on 3 consecutive 24-h dietary recalls in each round.Sex-specific Cox regression models will be used to estimate the relative risk.Results from our work will be used to provide epidemiological evidence for improving recommendation on SFAs intake for Chinese in dietary guidelines.

Conditions

Timeline

Start date
1989-01-01
Primary completion
2011-12-31
Completion
2012-12-31
First posted
2017-09-13
Last updated
2024-03-15

Source: ClinicalTrials.gov record NCT03281512. Inclusion in this directory is not an endorsement.

Saturated Fatty Acids Intake and Mortality, Diabetes, Hypertension and Overweight (NCT03281512) · Clinical Trials Directory